TECP
OKUR

Trails Edge Capital Partners’s OnKure Therapeutics OKUR Stock Holding History

Trails Edge Capital Partners’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.56M Buy
+1,438,456
New +$6.17M 1.04% 31

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Trails Edge Capital Partners's OKUR Position: Q2 2026 in Review

Trails Edge Capital Partners opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 1,438,456 shares worth $6.56M. The stake represents 1.04% of the portfolio and ranks #31 among its holdings.

67 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Trails Edge Capital Partners held 1,438,456 shares of OnKure Therapeutics worth $6.56M as of Q2 2026.
  • OnKure Therapeutics was a new Trails Edge Capital Partners position in Q2 2026.
  • OnKure Therapeutics made up 1.04% of Trails Edge Capital Partners's portfolio in Q2 2026, its #31 holding.
  • 67 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Trails Edge Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.